Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
19736 | 427 | 36.9 | 79% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
892 | 10711 | JOURNAL OF INTERFERON RESEARCH//ISG15//JOURNAL OF INTERFERON AND CYTOKINE RESEARCH |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ADENOVIRAL MEDIATED INTERFERON ALPHA | Author keyword | 6 | 100% | 1% | 4 |
2 | GENE IMMUNE MED | Address | 3 | 42% | 1% | 5 |
3 | CANC BIOL 173 | Address | 3 | 28% | 2% | 8 |
4 | SECT STUDIES HOST IMMUNE PONSE | Address | 3 | 28% | 2% | 8 |
5 | GELPART | Author keyword | 2 | 67% | 0% | 2 |
6 | ADENOVIRAL MEDIATED INTERFERON ALPHA TREATMENT | Author keyword | 1 | 100% | 0% | 2 |
7 | CATIONIC MULTILAMELLAR LIPOSOMES | Author keyword | 1 | 100% | 0% | 2 |
8 | GELATIN CONJUGATION | Author keyword | 1 | 100% | 0% | 2 |
9 | INTEGRATED BIOL SCI PROGRAM | Address | 1 | 50% | 0% | 2 |
10 | UNIT 0018 5 | Address | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FRIEND LEUKEMIA CELLS | 9 | 43% | 4% | 17 |
2 | CATIONIC MULTILAMELLAR LIPOSOMES | 8 | 100% | 1% | 5 |
3 | RNA HYBRIDIZATION TECHNIQUE | 7 | 32% | 4% | 19 |
4 | OVERCOMES RESISTANCE | 7 | 57% | 2% | 8 |
5 | MEDIATED SYSTEMIC DELIVERY | 7 | 67% | 1% | 6 |
6 | NUDE MOUSE BRAIN | 5 | 60% | 1% | 6 |
7 | SYSTEMIC IMMUNITY | 5 | 24% | 4% | 18 |
8 | CAUSES REGRESSION | 4 | 56% | 1% | 5 |
9 | GELATINASE PRODUCTION | 4 | 36% | 2% | 8 |
10 | CARCINOEMBRYONIC ANTIGEN PRODUCTION | 3 | 60% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon-alpha 2b Formulated in Syn3 for Bacillus Calmette-Guerin Failures in Nonmuscle Invasive Bladder Cancer | 2013 | 7 | 21 | 52% |
Interferon-alpha in tumor immunity and immunotherapy | 2002 | 195 | 93 | 34% |
Interferon-beta gene therapy for cancer: Basic research to clinical application | 2004 | 52 | 24 | 54% |
Role of type I interferon in inducing a protective immune response: Perspectives for clinical applications | 2015 | 1 | 55 | 20% |
Endogenous type I interferons as a defense against tumors | 2002 | 57 | 37 | 49% |
Wherefore interferon? | 1997 | 58 | 50 | 32% |
Interferon-alpha as Antiviral and Antitumor Vaccine Adjuvants: Mechanisms of Action and Response Signature | 2012 | 10 | 71 | 17% |
Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder | 2001 | 40 | 92 | 26% |
Cytokines as a link between innate and adaptive antitumor immunity | 2002 | 171 | 56 | 11% |
Perioperative IFN-alpha a to avoid surgically induced immune suppression in colorectal cancer patients | 2006 | 14 | 54 | 22% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GENE IMMUNE MED | 3 | 42% | 1.2% | 5 |
2 | CANC BIOL 173 | 3 | 28% | 1.9% | 8 |
3 | SECT STUDIES HOST IMMUNE PONSE | 3 | 28% | 1.9% | 8 |
4 | INTEGRATED BIOL SCI PROGRAM | 1 | 50% | 0.5% | 2 |
5 | UNIT 0018 5 | 1 | 100% | 0.5% | 2 |
6 | YAGI MEM PK | 1 | 18% | 1.2% | 5 |
7 | CELL BIOL 173 | 1 | 33% | 0.5% | 2 |
8 | RECH BIOMED CRODELIERS | 1 | 50% | 0.2% | 1 |
9 | SOC AZIONI | 1 | 50% | 0.2% | 1 |
10 | HEMATOL ONCOL MOL THER EUT | 1 | 19% | 0.7% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000204208 | INTERFERON RECEPTOR//IFNAR2//IFNAR1 |
2 | 0.0000116247 | ORAL PROTEINS//IFR Y1221//UPR 9045 CNRS |
3 | 0.0000104369 | JOURNAL OF INTERFERON RESEARCH//TEXAS REPORTS ON BIOLOGY AND MEDICINE//JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS |
4 | 0.0000098804 | ADV CELL MOL THER Y//SHUNDE PEOPLES HOSP//TUMOR VACCINE |
5 | 0.0000088708 | BIOL GENET BACTERIAL CELL WALL//FC GAMMA RIII ALPHA//HUMAN INJECTIONS |
6 | 0.0000075496 | TUMOR TROPISM//MOL NEUROTHER Y IMAGING//VET BIOCHEM IMMUNOL |
7 | 0.0000073726 | BRAIN TUMOR PROGRAM//GLIOMA IMMUNOTHER Y GRP//GL261 |
8 | 0.0000069416 | TUMOR GRAFT//MACROTRANSFECTION//MINITRANSFECTION |
9 | 0.0000065924 | RNASE L//2 5A//SECT BIOMED CHEM |
10 | 0.0000059358 | BIOCHEMOTHERAPY//METASTATIC MELANOMA//DACARBAZINE |